patient_filename,t_base,canon_truth_base,rag_raw_t_reasoning,rag_raw_t_stage,is_error_base,t_meth,canon_truth_meth,ltm_rag1_t_reasoning,ltm_rag1_t_stage,is_error_meth
TCGA-5L-AAT0.F9B6971F-23C0-465F-BFEC-778BF228A1AE,1,T2,"According to the pathology report, the patient has a right breast wide excision with an invasive lobular carcinoma that measures 0.4 cm in the largest diameter.   To determine the pathologic T stage (pT), we will use the TNM Staging System guidelines from the AJCC. Based on these guidelines, the primary tumor (T) is classified according to the size of the tumor.  The options for T stage are: T1 (tumor ≤ 20 mm in greatest dimension), T2 (tumor > 20 mm but ≤ 50 mm in greatest dimension), T3 (tumor > 50 mm in greatest dimension), and T4 (tumor of any size with direct extension to the chest wall and/or to the skin).  The report indicates that the tumor measures 0.4 cm in the largest diameter which falls under T1 (tumor ≤ 20 mm in greatest dimension).  However, T1 is further divided into T1mi (tumor ≤ 1 mm in greatest dimension), T1a (tumor >1 mm but ≤ 5 mm in greatest dimension), T1b (tumor >5 mm but ≤ 10 mm in greatest dimension), and T1c (tumor >10 mm but ≤ 20 mm in greatest dimension).  Since the tumor measures 0.4 cm in the largest diameter, it falls under T1c (tumor >10 mm but ≤ 20 mm in greatest dimension).  Therefore, the patient's pathologic T stage is T1c.",T1c,True,1,T2,"The pathology report states that the gross description of the specimen measures 2.2 x 1.2 x 0.4 cm. The microscopic examination reveals an invasive lobular carcinoma that measures 0.4 cm in the largest diameter. According to the rules provided, T1 includes invasive breast carcinomas that are 2 cm or less in size. Since the invasive lobular carcinoma measures 0.4 cm, it falls under T1. The specific substage T1mi, T1a, T1b, or T1c cannot be determined based solely on the information provided in the report.",T1,True
TCGA-5L-AAT1.B5CA42BB-9514-42C6-9FB0-C8889C1DC51A,1,T2,"According to the pathology report, the patient has 'Invasive lobular carcinoma, grade 1, measuring 1.1 cm in the largest diameter' in the right breast. There is no mention of direct extension to the chest wall or skin ulceration/nodules. Based on this information, we can determine the pathologic T stage (pT) using the AJCC's TNM Staging System guidelines. \\n\\nThe relevant T category definition from the guidelines is: \\n\\nT1: Tumor ≤ 20 mm in greatest dimension \\n\\nThe patient's tumor measures 1.1 cm in the largest diameter, which falls within the T1 category. Therefore, the patient's pathologic T stage is T1.",T1,True,1,T2,"Based on the pathology report, the patient has invasive lobular carcinoma in the right breast, which measured 3.5 x 2.5 x 0.8 cm on gross examination. The report also mentions that the largest diameter of the tumor was 1.1 cm. According to rule 1, T1 stage includes invasive breast carcinomas that are 2 cm or less in size. The patient's tumor is 1.1 cm in the largest diameter, which falls under T1 stage. However, the report does not provide information about the specific subcategory of T1 (T1mi, T1a, T1b, or T1c). Therefore, the T stage for this patient is T1.",T1,True
TCGA-A2-A0CK.B065FC65-CD33-4878-AE2C-7E8C04F5ECAB,2,T3,"The report states that 'TUMOR SIZE: 0.5 CM BY MICROSCOPY' and 'FINAL DIAGNOSIS: BREAST, RIGHT INFERIOR LATERAL RETRO-AREOLA, EXCISION : INFILTRATING LOBULAR CARCINOMA. SURGICAL MARGINS POSITIVE FOR TUMOR.' in the 'FINAL DIAGNOSIS' section. According to the AJCC TNM Staging System for breast cancer, T1 indicates a tumor up to 2 cm in size. Since the report states that the tumor size is 0.5 cm, it falls under T1. Therefore, the pathologic T stage of the patient's breast cancer is T1.",T1,True,2,T3,"The pathology report states that the 'TUMOR SIZE: 0.5 CM BY MICROSCOPY.' This measurement refers to the size of the invasive component of the tumor. According to the rules provided, T1 includes invasive breast carcinomas that are 2 cm or less in size. Since the tumor size in this case is 0.5 cm, which is less than 2 cm, the patient's breast cancer falls under the T1 category. The report does not provide information about the presence or absence of satellite nodules, ulceration, or inflammatory carcinoma, so we cannot make a more specific T1 subclassification (T1mi, T1a, T1b, or T1c). Therefore, the patient's pathologic T stage is T1.}",T1,True
TCGA-A2-A0ET.E9D3FFF1-5FB2-4F17-9C1D-D9775E3CC5AC,1,T2,"To determine the pathologic T stage of the patient's breast cancer, we will use the AJCC's TNM Staging System guidelines. The T stage is based on the size of the tumor. According to the report, the tumor size (greatest dimension) is 1.9 cm, as measured microscopically. Now, let's compare this measurement with the T stage categories from the AJCC guidelines:"",""explanation"":""T1: Tumor ≤ 20 mm in greatest dimension."",""decision"":""The tumor size is 1.9 cm (19 mm), which falls under the T1 category. However, there is a further subdivision of T1 into T1a, T1b, T1c. To determine the correct subdivision, we need to look at the subcategories:"",""subcategories"":[{""subcategory"":""T1a: Tumor >1 mm but ≤ 5 mm in greatest dimension."",""not_applicable"":true},{""subcategory"":""T1b: Tumor >5 mm but ≤ 10 mm in greatest dimension."",""not_applicable"":true},{""subcategory"":""T1c: Tumor >10 mm but ≤ 20 mm in greatest dimension."",""applicable"":true}],""final_decision"":""Since the tumor size is greater than 10 mm but less than or equal to 20 mm, the correct T stage is T1c.""}  According to the report, the tumor size is 1.9 cm (19 mm), which falls under the T1 category. However, there is a further subdivision of T1 into T1a, T1b, T1c. To determine the correct subdivision, we need to look at the subcategories: 1. T1a: Tumor >1 mm but ≤ 5 mm in greatest dimension. 2. T1b: Tumor >5 mm but ≤ 10 mm in greatest dimension. 3. T1c: Tumor >10 mm but ≤ 20 mm in greatest dimension. The report states that the tumor size is 1.9 cm (19 mm), which falls under the T1c subcategory (tumor >10 mm but ≤ 20 mm in greatest dimension). Therefore, the pathologic T stage of the patient's breast cancer is T1c.",T1c,True,1,T2,"Based on the pathology report, the patient's breast cancer has a greatest dimension of 1.9 cm, as measured microscopically. According to the rules provided, T1 includes invasive breast carcinomas that are 2 cm or less in size. T1 can be further divided into T1mi (microinvasion 0.1 cm or less), T1a (0.1 cm but less than 0.5 cm in size), T1b (0.5 cm but less than 1 cm in size), and T1c (1 cm but less than 2 cm in size). The patient's tumor size of 1.9 cm falls within the T1c category, which includes tumors that are 1 cm but less than 2 cm in size. Therefore, the patient's pathologic T stage is T1c.",T1c,True
TCGA-A2-A0SV.161E2817-7DB2-46F8-BFEB-256DBBEFE633,1,T2,"To determine the pathologic T stage of the patient's breast cancer, we will follow the AJCC's TNM Staging System guidelines. The T stage is based on the size of the tumor and the extent of its direct extension. According to the pathology report, the patient has an infiltrating ductal carcinoma in the right breast, with a greatest dimension of 4.5 cm.  \\nNow let's examine the relevant T stage definitions from the AJCC guidelines: \\nT1: The tumor is 20 millimeters or less in greatest dimension. \\nT2: The tumor is more than 20 millimeters but not more than 50 millimeters in greatest dimension. \\nT3: The tumor is more than 50 millimeters in greatest dimension. \\nT4: The tumor of any size with direct extension to the chest wall and/or to the skin (ulceration or skin nodules). \\nBased on the report, the tumor size is 4.5 cm (45 millimeters), which falls under the T2 category. However, the report also mentions skin involvement (present). This direct extension to the skin classifies the tumor as T4b. Therefore, the patient's pathologic T stage is T4b.",T4b,True,1,T2,"The report states that the tumor size (greatest dimension) is 4.5 cm, as measured grossly. According to the rules provided, this would fall under T2, which includes invasive breast carcinomas that are more than 2 cm but not more than 5 cm in size. However, the report also states that the tumor has direct extension to the skin (skin involvement is present) and there are satellite nodules present in other quadrants, which are not measured separately as separate primary tumors but appear to have arisen from intramammary lymphatic spread. These findings meet the criteria for T4d, which includes invasive breast carcinomas that have spread to the skin, resulting in satellite nodules. Therefore, the T stage for this patient's breast cancer is T4d.",T4d,True
TCGA-A2-A1FX.EAFC71A1-D6FC-46EA-BC47-D054C497D705,2,T3,"The patient's pathologic T stage can be determined by reviewing the findings from the breast mass excision in container C and the additional right breast tissue in container E. \n1. From container C, we learn that the tumor mass in the breast is 4.7 cm in greatest dimension (T2).  \n2. The report also states that the tumor involves the superior, inferior, medial, and anterior surgical margins (T2).  \\n3. Furthermore, the tumor is very close to the posterior and lateral surgical margins, with small indurated nodules (T3). However, to qualify for T3, the tumor must have direct extension to the chest wall and/or to the skin (ulceration or skin nodules). In this case, there is no mention of direct extension to the chest wall or skin involvement in the report.  \\n4. Therefore, based on the information provided, the patient's pathologic T stage is T2 (tumor >20 mm but <= 50 mm in greatest dimension).}",T2,True,2,T3,"The report states that the 'RIGHT BREAST MASS - F.S. - TUMOR MASS 4.7 CM. AND INVOLVING SUPERIOR, INFERIOR, MEDIAL, ANTERIOR SURGICAL MARGINS. TUMOR IS ALSO VERY CLOSE TO POSTERIOR AND LATERAL SURGICAL MARGINS. (WITH SMALL INDURATED NODULES)'. This indicates that the tumor is more than 2 cm but not more than 5 cm in size, which corresponds to T2. The report also states that 'D. AXILLARY CONTENTS - POSITIVE FOR METASTASIS IN FOUR OF TWENTY TWO LYMPH NODES, TWO OF FOUR DISPLAY SUBCAPSULAR METASTASIS MEASURING MORE THAN 2 MM. IN GREATEST. DIMENSION, ONE OF FOUR DISPLAYS MICROMETASTASIS IN SUBCAPSULAR SINUS. MEASURING LESS THAN 2 MM. AND REMAINING ONE OF FOUR DISPLAYS ISOLATED. POSITIVE CELLS IN SUBCAPSULAR SINUSES (4/22)', but this information is not used to determine the T stage, only the N stage. Therefore, the pathologic T stage of the patient's breast cancer is T2.",T2,True
TCGA-A2-A3XS.DD5295D4-3896-4AA5-AF75-30AEA45D1652,0,T1,"The patient's pathology report includes the following findings: """,T2,True,0,T1,"The report states that the largest mass of the tumor measures 3.0 cm in greatest dimension (specimen A, gross description). According to the rules provided, this falls under the T2 category, which includes invasive breast carcinomas that are more than 2 cm but not more than 5 cm in size. Therefore, the pathologic T stage of the patient's breast cancer is T2.",T2,True
TCGA-A2-A4S2.4A5630FF-0ADC-4E69-B22A-02F1F34F61F9,2,T3,"To determine the pathologic T stage of the patient's breast cancer, we will follow the AJCC's TNM Staging System guidelines. The T stage is based on the size of the primary tumor.""T1"" tumors are 20mm or less in greatest dimension.""T2"" tumors are more than 20mm but not more than 50mm in greatest dimension.""T3"" tumors are more than 50mm in greatest dimension.""T4"" tumors are of any size with direct extension to the chest wall and/or to the skin."",n""The report mentions that there is a firm gray-tan mass in the 12-1 o'clock area, which measures 5.8 cm from superior to inferior, 2.5 cm from anterior to posterior, and 4 cm from medial to lateral. This is greater than 20mm in greatest dimension, but not more than 50mm, so it falls under the category of a T2 tumor.",T2,True,2,T3,"The report mentions that the 'invasive component has a maximum gross dimension of 5.8 cm'. According to the rules provided, this would fall under the T2 category, which includes invasive breast carcinomas that are more than 2 cm but not more than 5 cm in size. Therefore, the pathologic T stage of the patient's breast cancer is T2.",T2,True
TCGA-A8-A07E.E20AC0FF-43C4-49EA-9E33-764E553933B7,3,T4,"The pathologic T stage of a breast cancer patient can be determined by using the greatest dimension of the invasive tumor. In this case, the report states 'tumor diameter: 3.5 cm'. According to the AJCC's TNM Staging System guidelines, T1 includes tumors up to 20 mm, T2 includes tumors between 20 mm and 50 mm, T3 includes tumors larger than 50 mm, and T4 includes tumors of any size with direct extension to the chest wall and/or to the skin. Therefore, the patient's pathologic T stage is T2, as the tumor diameter is larger than 20 mm but not larger than 50 mm.",T2,True,3,T4,"The pathology report indicates that the patient has a moderately differentiated invasive ductal carcinoma with a tumor diameter of 3.5 cm. According to the rules provided, T1 stage includes tumors that are 2 cm or less in size, and T2 stage includes tumors that are more than 2 cm but not more than 5 cm in size. The tumor in this case is 3.5 cm in size, which falls within the T2 stage range (more than 2 cm but not more than 5 cm). Therefore, the pathologic T stage of the patient's breast cancer is T2. This determination is based solely on the tumor size information provided in the pathology report and does not take into account other factors such as clinical examination, imaging studies, or the presence of other features such as skin or chest wall involvement.",T2,True
TCGA-A8-A07L.5D93AE27-79A0-4809-AE7C-54814CED0851,2,T3,"The report states that the patient has an invasive ductal breast carcinoma that measures a maximum of 3.4 cm (3.4 > 2.0 cm). This information corresponds to the T2 category in the AJCC's TNM Staging System guidelines, which defines T2 as 'Tumor >20 mm but ≤ 50 mm in greatest dimension.' Therefore, the pathologic T stage of the patient's breast cancer is T2.",T2,True,2,T3,"The report states that the maximum size of the invasive ductal carcinoma is 3.4 cm (M-8500/3, G 3, pT 3). According to the rules provided, a T3 stage tumor is defined as an invasive breast carcinoma that is more than 5 cm in size or tumors of any size with direct extension to the chest wall or skin. In this case, the tumor size is 3.4 cm, which is more than 2 cm but not more than 5 cm. However, the report also mentions evidence of carcinomatous lymphangitis and two axillary lymph node metastases, which could indicate direct extension to the lymphatic system. However, the rules do not mention lymphatic extension as a criterion for T stage determination. Therefore, based solely on the information provided in the report and the rules, the T stage of this breast cancer would be T2 (more than 2 cm but not more than 5 cm in size).",T2,True
TCGA-AN-A0AL.20F4DBD9-02FA-4FFD-AEF5-234910D31263,3,T4,"The pathologic T stage of a breast cancer patient can be determined by using the information from the pathology report and the AJCC's TNM Staging System guidelines. In this case, the report mentions 'T Stage: 4' and the diagnosis is 'Infiltrative ductal carcinoma'. However, the AJCC guidelines state that T4 includes tumors of any size with direct extension to the chest wall and/or to the skin. The report does not mention any direct extension to the chest wall or skin, so the T4 designation from the report may not be accurate according to the AJCC guidelines. Instead, we need to look at the size of the tumor. The report mentions 'Tumor ≤ 20 mm in greatest dimension', which corresponds to T1. Therefore, the patient's pathologic T stage is T1.",T1,True,3,T4,"The pathology report provides the size of the tumor under the T Stage field, which is '4'. However, this is not a valid size for determining the T stage as it does not correspond to any of the categories mentioned in the rules. The number '4' in this context most likely indicates that the tumor size was not measured or not recorded in the report. Therefore, it is not possible to accurately determine the T stage based solely on this report."",""decision"":""Insufficient information to determine T stage""}",Insufficient information to determine T stage,True
TCGA-AN-A0XN.4C9C9D24-07E1-47BE-8D34-F94693576BD2,1,T2,"The pathologic T stage of a breast cancer patient can be determined by using the information from the pathology report and the AJCC's TNM Staging System guidelines. In this case, the report mentions 'T Stage: 2'. According to the AJCC guidelines, T Stage 2 refers to 'Tumor >10 mm but ≤ 20 mm in greatest dimension'. Therefore, the pathologic T stage of the patient is T1c.",T1c,True,1,T2,"The pathology report provides the tumor size as 2 cm or less, which corresponds to T1 stage. However, it does not provide the exact size of the tumor within the T1 range (T1mi, T1a, T1b, or T1c). Therefore, based on the information provided, we can only determine that the T stage is T1, but we cannot specify the exact substage. The T stage could be T1mi, T1a, T1b, or T1c, depending on the exact size of the tumor.",T1,True
TCGA-AN-A0XR.1351520E-9B6A-4F06-B631-DF374396C7E6,1,T2,"The pathologic T stage for breast cancer is determined based on the size of the tumor. According to the report, the tumor size is 20 mm or less in greatest dimension, which falls under T1. However, T1 is further divided into T1mi, T1a, T1b, and T1c based on the exact size of the tumor. The report does not provide the exact size within the T1 range, only mentioning 'T Stage: 2'. But since T1c is the maximum size within T1, we can assume that the tumor size is equal to or less than 20 mm but greater than 10 mm. Therefore, the pathologic T stage of this patient's breast cancer is T1c.",T1c,True,1,T2,"The pathology report provides the tumor size as '2 cm or less', which corresponds to T1 stage according to the rules. However, it does not provide a more specific size within the T1 range (T1mi, T1a, T1b, or T1c). Therefore, the most general T1 stage can be assigned. The report also mentions a N Stage of 2b, but this does not affect the T stage determination.",T1,True
TCGA-AN-A0XS.D5C9D3FF-3799-4773-8A86-B000DBE42BD8,1,T2,"To determine the pathologic T stage of the patient's breast cancer, we will follow the AJCC's TNM Staging System guidelines. The T stage is based on the size of the primary tumor. According to the pathology report, the patient is a female with a diagnosis of breast cancer, specifically infiltrative ductal carcinoma. The tissue specimen was procured through surgery, and the tumor size is specified as T1."",\",T1,True,1,T2,"The pathology report provided does not include information about the size of the tumor, which is a critical factor in determining the T stage of breast cancer. The rules state that T1 tumors are 2 cm or less, T2 tumors are more than 2 cm but not more than 5 cm, T3 tumors are more than 5 cm or have direct extension to the chest wall or skin, and T4 tumors have spread to the chest wall and/or skin. Without information about the size of the tumor, it is not possible to accurately determine the T stage based on this report alone.",Unable to determine based on provided information,True
TCGA-AN-A0XT.3C94BBAC-923E-43F0-B5DC-01207868AD05,1,T2,"The pathologic T stage for breast cancer is determined based on the size of the tumor. According to the report, the tumor size is 1c, which corresponds to a primary tumor size of >10 mm but ≤ 20 mm. Therefore, the pathologic T stage for this patient is T1c.",T1c,True,1,T2,"The pathology report indicates that the patient is diagnosed with Infiltrative Ductal Carcinoma, a type of breast cancer, and the T stage is specified as 1c. According to the rules provided, T1 stage is further divided into T1mi, T1a, T1b, and T1c. T1c includes tumors that are 1 cm but less than 2 cm in size. Therefore, based on the information provided in the pathology report, the patient's T stage is T1c, which means the tumor is 1 cm but less than 2 cm in size.",T1c,True
TCGA-AO-A0J5.5EFC16F4-7FC7-479E-93F7-AEDC2D350A22,3,T4,"The report mentions that the 'INVASIVE CARCINOMA shows...measuring at least 10 CM in largest dimension GROSSLY.' This is consistent with the T3 category in the AJCC's TNM Staging System guidelines, which defines T3 as 'Tumor >50 mm in greatest dimension.' However, the report also states that 'T1 includes T1mi,' and 'T1mi' is defined as 'Tumor ≤ 1 mm in greatest dimension.' Since the tumor in this case is larger than 1 mm but not larger than 10 cm, it falls under the T1 category. But, because the T1 category includes T1mi, and the report states that the tumor is at least 10 cm, the correct T stage is T3. This is consistent with the guideline's definition of T3 as 'Tumor >50 mm in greatest dimension' and the report's measurement of the tumor as 'at least 10 CM in largest dimension GROSSLY.'",T3,True,3,T4,"The report states that the largest dimension of the invasive carcinoma is at least 10 cm (`measuring at least 10 CM in largest dimension grossly`). According to the rules provided, this would put the patient in the T3 stage: `T3: This stage includes invasive breast carcinomas that are more than 5 cm in size.` The report also mentions that the skin is involved by invasive carcinoma by direct extension (`THE SKIN IS INVOLVED BY INVASIVE CARCINOMA BY DIRECT EXTENSION INTO THE. DERMIS.`) and the attached skeletal muscle is extensively involved by invasive carcinoma by direct extension (`THE ATTACHED SKELETAL MUSCLE IS EXTENSIVELY INVOLVED BY INVASIVE CARCINOMA. BY DIRECT EXTENSION.`). These findings would also support a T3 stage. However, the size of the tumor is the most significant factor in determining the T stage in this case, so the final decision is T3.",T3,True
TCGA-AO-A0J9.1E3F3136-6D86-4470-85AA-55B11C9E24CD,1,T2,"The report states that 'INVASIVE LOBULAR CARCINOMA, CLASSICAL TYPE, MEASURING 0.4 CM IN. LARGEST DIMENSION MICROSCOPICALLY' was identified. According to the AJCC TNM Staging System for breast cancer, T1 refers to a tumor that is 20mm or less in greatest dimension. Since the tumor in this report measures 0.4 cm, which is equivalent to 4mm, it falls within the T1 category. The specific subcategory T1mi (microinvasion) is used for a tumor 1mm or less in greatest dimension, T1a for a tumor >1 mm but ≤ 5 mm, T1b for a tumor >5 mm but ≤ 10 mm, and T1c for a tumor >10 mm but ≤ 20 mm. In this case, the tumor is larger than 1mm but less than or equal to 5mm, so the correct T stage is T1b.",T1b,True,1,T2,"[{""step"":1,""description"":""Examining the report, we see that the patient has a right invasive lobular carcinoma with the largest dimension measured microscopically as 0.4 cm.""},{""step"":2,""description"":""Referring to the rules for determining the T stage, T1 includes invasive breast carcinomas that are 2 cm or less in size. The patient's tumor is 0.4 cm, which falls within this range.""},{""step"":3,""description"":""Further classification of T1 can be made based on size: T1mi (microinvasion 0.1 cm or less), T1a (0.1 cm but less than 0.5 cm in size), T1b (0.5 cm but less than 1 cm in size), and T1c (1 cm but less than 2 cm in size). However, the report does not provide enough information to make this distinction.""},{""step"":4,""description"":""Therefore, based on the information provided in the report and the rules, the patient's pathologic T stage is T1.""}]",T1,True
TCGA-AO-A0JG.3671D46F-6D69-42DA-9830-24F67EB8B0B6,1,T2,"The report states that the largest dimension of the invasive ductal carcinoma is 2.3 cm. According to the AJCC TNM Staging System guidelines, T1 indicates a tumor up to 2 cm in size, T2 is a tumor between 2 and 5 cm, T3 is a tumor more than 5 cm, and T4 involves the chest wall or skin. Therefore, the patient's pathologic T stage is T1.",T1,True,1,T2,"The report states that the 'INVASIVE DUCTAL CARCINOMA, MIXED MUCINOUS & NOS TYPE AND WITH SOLID-PAPILLARY FEATURES, HISTOLOGIC GRADE III/III (SLIGHT OR NO TUBULE FORMATION), NUCLEAR GRADE II/III (MODERATE VARIATION IN SIZE AND SHAPE). MEASURING 2.3 CM IN LARGEST DIMENSION MICROSCOPICALLY' is present in the lower outer quadrant of the right breast. This information refers to the size and location of the invasive cancer. According to the rules provided, T1 includes invasive breast carcinomas that are 2 cm or less in size. Therefore, based on the information given in the report, the pathologic T stage of the patient's breast cancer is T1 (specifically T1c, as the size of the tumor is 2.3 cm, which is between 1 and 2 cm).",T1c,True
TCGA-AO-A1KP.467172CC-6EA1-435D-BDC1-D65FBF8EA0E8,0,T1,"To determine the pathologic T stage of the patient's breast cancer, we will follow the AJCC's TNM Staging System guidelines. The T stage is based on the size of the primary tumor.""T1"" tumors are 20mm or less in greatest dimension. Let's examine the report to find the size of the largest invasive tumor focus."",""steps"":[""The report mentions that there are multiple foci of invasive ductal carcinoma, with the largest one being 1.8 cm in size (located in the lower inner quadrant)."",""This indicates that the patient's breast cancer is larger than 20mm in greatest dimension."",""Therefore, based on the AJCC's TNM Staging System guidelines, the patient's pathologic T stage is T3, as T3 tumors are larger than 50mm in greatest dimension."",""However, it's important to note that the final T stage decision should be made by a healthcare professional who has access to the complete medical record and can consider all relevant factors, including any potential measurement errors or discrepancies.""]}",T3,True,0,T1,"To determine the pathologic T stage of the patient's breast cancer, we will examine the size of the tumor and any involvement of the chest wall or skin as described in the pathology report. According to the rules provided, we will consider the largest focus of invasive carcinoma to determine the T stage. Here is the step-by-step interpretation of the report:"",""steps"":[""Step 1: Identify the size of the largest focus of invasive carcinoma. According to the report, the largest invasive carcinoma focus measures 1.8 cm (see 'BREAST, LEFT¿ TOTAL NASTECTONY' in the DIAGNOSIS section)."",""Step 2: Check for any direct extension to the chest wall or skin. The report does not mention any direct extension to the chest wall or skin."",""Step 3: Based on the information provided, the largest focus of invasive carcinoma is 1.8 cm, and there is no direct extension to the chest wall or skin. Therefore, the patient's pathologic T stage is T2, as the tumor is more than 2 cm but not more than 5 cm in size.""]}",T2,True
TCGA-AO-A1KQ.EB5199BA-6164-4CFB-AFAA-B41544B83103,3,T4,"To determine the pathologic T stage of the patient's breast cancer, we will follow the AJCC's TNM Staging System guidelines. The T stage is based on the size of the primary tumor and its invasion into the surrounding tissue.""T1"": Tumor ≤ 20 mm in greatest dimension"". From the report, we can find the size of the tumor: ""INVASIVE DUCTAL CARCINOMA. NOS TYPE. HISTOLOGIC GRADE III/III (SLIGHT. OR NO TUBULE FORMATION), NUCLEAR GRADE III/III (MARKED VARIATION IN SIZE AND. SHAPE) MEASURING 2.2 CM IN LARGEST DIMENSION"". The tumor measures 2.2 cm in largest dimension, which falls under T1 category.""T1a"": Tumor >1 mm but ≤ 5 mm in greatest dimension"". ""T1b"": Tumor >5 mm but ≤ 10 mm in greatest dimension"". ""T1c"": Tumor >10 mm but ≤ 20 mm in greatest dimension"". Since the tumor measures 2.2 cm, which is greater than 10 mm but less than or equal to 20 mm, the patient's T stage is T1c.",T1c,True,3,T4,"To determine the pathologic T stage of the patient's breast cancer, we will follow the rules provided step-by-step. Based on the pathology report, the patient is a male with left breast cancer, specifically invasive ductal carcinoma (IDC).   \\n\\nThe report mentions that the 'INVASIVE DUCTAL CARCINOMA. NOS TYPE. HISTOLOGIC GRADE III/III (SLIGHT. OR NO TUBULE FORMATION), NUCLEAR GRADE III/III (MARKED VARIATION IN SIZE AND. SHAPE) MEASURING 2.2 CM IN LARGEST DIMENSION MICROSCOPICALLY.'  \\n\\nAccording to rule 1, T1 includes invasive breast carcinomas that are 2 cm or less in size. The report indicates that the size of the invasive ductal carcinoma is 2.2 cm, which is larger than 2 cm. Therefore, we can exclude T1 as a possible T stage.  \\n\\nLet's consider rule 2, T2 includes invasive breast carcinomas that are more than 2 cm but not more than 5 cm in size. The report indicates that the size of the invasive ductal carcinoma is 2.2 cm, which falls within the range of T2. Therefore, the patient's breast cancer can be classified as T2.  \\n\\nWe can exclude rules 3 and 4 because they refer to tumors that are larger than 5 cm or have spread to the chest wall and/or skin, which is not the case based on the pathology report.  \\n\\nTherefore, based on the pathology report and the rules provided, the patient's breast cancer can be classified as T2.",T2,True
TCGA-AR-A0TQ.6061FCA5-A113-4985-905D-E17020F6933E,2,T3,"The report states that the patient had a 'single mass (7.2 x 4.5 x 3.4 cm)' in the breast. According to the AJCC guidelines, T1 tumors are 20mm or less in greatest dimension, T2 tumors are more than 20mm but not more than 50mm, and T3 tumors are more than 50mm. Given that the tumor size in this report is 7.2 cm (which is equivalent to 72mm) in greatest dimension, it exceeds the limit for T2 tumors and does not meet the criteria for T3 tumors. Therefore, the pathologic T stage of the patient's breast cancer is T2, as it is more than 20mm but not more than 50mm in greatest dimension.",T2,True,2,T3,"[The pathologic T stage is determined by the size of the tumor in the breast.] The report states that the patient underwent a right simple mastectomy and the pathology revealed 'infiltrating ductal carcinoma, Nottingham grade III (of III) [tubules. 3/3, nuclei 3/3, mitoses 2/3; Nottingham score 8/9], forming a single mass (7.2 x 4.5 x 3.4 cm) located in. the upper inner and upper central quadrant of the breast [AJCC pT2].' The size of the tumor is 7.2 cm in the greatest dimension. According to the rules provided, T2 includes invasive breast carcinomas that are more than 2 cm but not more than 5 cm in size. Since the tumor size is 7.2 cm, which is greater than 5 cm, this tumor does not meet the criteria for T1 or T2. The report also states that there is no direct extension to the chest wall or skin. Therefore, the tumor does not meet the criteria for T3. However, the tumor size is greater than 5 cm and it is an invasive breast carcinoma, so it meets the criteria for T4. But, there is no mention of ulceration, satellite nodules, or inflammatory carcinoma in the report. Therefore, the patient's pathologic T stage is T4, but without any substaging information (T4N0M0).",T4,True
TCGA-AR-A0TW.F832C787-3668-475F-8F67-6342DA3777F4,2,T3,"The report mentions a largest tumor that is a Nottingham grade III (of III) ductal adenocarcinoma with a greatest dimension of 5.5 cm, and multiple (3) additional tumors (all Nottingham grade II (of III) with greatest dimensions of 2.0 cm, 1.5 cm, and 1.0 cm). The AJCC guidelines state that T1 includes T1mi, and T1 tumors are ≤ 20 mm in greatest dimension. The largest tumor described in the report is 5.5 cm, which is greater than 20 mm and therefore does not meet the criteria for T1. The next category, T2, includes tumors >20 mm but ≤ 50 mm in greatest dimension. The largest tumor described in the report (5.5 cm) falls within this range, so the pathologic T stage for this patient is T2.",T2,True,2,T3,"The report mentions a largest tumor with a greatest dimension of 5.5 cm. According to rule 2, T2 includes invasive breast carcinomas that are more than 2 cm but not more than 5 cm in size. However, the largest tumor in this report is larger than 5 cm, which means it does not meet the criteria for T2. The report also does not mention any direct extension to the chest wall or skin, which would be required for a T3 classification. Therefore, we can eliminate T1, T2, and T3. The report mentions that there are multiple additional tumors, but it does not provide enough information about these tumors to include them in the T stage determination. Based on the information provided, the largest tumor is a T4 because it has a greatest dimension of more than 5 cm without any mention of direct extension to the chest wall or skin, ulceration, satellite nodules, or inflammatory carcinoma. However, it is important to note that a healthcare professional would need to consider other factors, such as clinical examination and imaging studies, to make a final determination of the T stage.",T4,True
TCGA-AR-A1AM.10C43124-3C21-443C-8268-23BF8A4D317E,2,T3,"According to the AJCC's TNM Staging System guidelines, the T stage is determined by the size of the primary tumor. In this report, there are two separate tumors: a 1.1 x 0.9 x 0.8 cm infiltrating lobular carcinoma (Tlc) and a 1.7 x 1.5 x 0.9 cm infiltrating ductal carcinoma (T1c). The larger of the two tumors is the infiltrating ductal carcinoma, which measures 1.7 cm in its greatest dimension. Therefore, the patient's pathologic T stage is T2 (Tumor >20 mm but <= 50 mm in greatest dimension).",T2,True,2,T3,[{,T1c,True
TCGA-AR-A1AV.5AD5B38F-5CC1-4A2F-96E6-F344D8FE0149,1,T2,"According to the pathology report, the patient had a left breast modified radical mastectomy for an infiltrating ductal carcinoma located in the retroareolar region, which formed a mass of 2.8 x 2.3 x 2.1 cm. The report also mentions that the tumor involves the overlying skin. Based on the AJCC TNM staging system for breast cancer, T stage is determined by the size of the primary tumor and whether it directly extends to the chest wall and/or skin. In this case, the primary tumor is larger than 20 mm but not larger than 50 mm and directly extends to the skin, which corresponds to T4b. Therefore, the patient's pathologic T stage is T4.",T4,True,1,T2,"[The report states: 'Infiltrating ductal carcinoma, Nottingham grade II (of. III) [tubules 3/3, nuclei 2/3, mitoses 2/3; Nottingham score 779], forming a mass (2.8 x 2.3 x 2.1. cm) located in the retroareolar region of the breast. The tumor involves the. overlying skin [AJCC pT4].' According to the rules provided, T4 stage includes invasive breast carcinomas that have spread to the chest wall and/or the skin, resulting in ulceration or satellite nodules. The report indicates that the tumor involves the overlying skin, which falls under the T4 category. Therefore, the pathologic T stage of the patient's breast cancer is T4.]",T4,True
TCGA-AR-A24H.C373F2EE-C601-4E17-8E2D-D9BC6AC0301A,1,T2,"To determine the pathologic T stage of the patient's breast cancer, we will use the information from the pathology report and the AJCC's TNM Staging System guidelines. The key information from the report is: 1) The size of the invasive lobular carcinoma is 2.8 x 2.6 x 6.0 x 2.0 cm. 2) No lymphovascular involvement or carcinoma in situ component is identified. 3) The surgical resection margins are negative for tumor. 4) The uninvolved breast tissue shows duct ectasia and stromal fibrosis. 5) No lymph nodes are positive for tumor. According to the AJCC guidelines, the T stage is determined by the size of the primary tumor. Since the largest dimension of the tumor is 6.0 cm (2.8 or 2.6 cm could also be used, as they are close in size), the patient's T stage is T3: Tumor >50 mm in greatest dimension. This is because the tumor measures more than 50 mm but not more than 50 mm in greatest dimension.",T3,True,1,T2,"Based on the pathology report, the patient has invasive lobular carcinoma in the right breast, with a largest dimension of 2.8 x 2.6 x 6 x 2 cm. The report also mentions that there is no lymphovascular involvement or carcinoma in situ component identified, and the surgical resection margins are negative for tumor. The largest dimension of the tumor is used to determine the T stage, and in this case, it is less than 2 cm (2.8 cm to be exact). Therefore, the T stage is T1. The T1 stage can be further divided based on the size of the tumor, but the report does not provide enough information to determine the exact T1 subcategory (mi, a, b, or c).",T1,True
TCGA-AR-A2LK.73FFBADB-37C0-4F17-8C95-F8DC94EF1AD3,2,T3,"According to the AJCC's TNM Staging System guidelines, the T stage is based on the size of the primary tumor. In this report, we have the following measurements: a 5.2 x 3.0 x 2.6 cm mass in the wide local excision and two additional nodules of 0.7 x 0.6 x 0.5 cm and 0.5 x 0.4 x 0.4 cm in the total mastectomy. The largest of these is the 5.2 cm mass in the wide local excision. Now let's compare this with the T stage definitions:",T2,True,2,T3,"To determine the T stage of the breast cancer patient, we will consider the size of the tumor and whether it has directly extended to the chest wall or skin. We will ignore any substaging information."",""steps"":[""The report mentions a mass of 5.2 x 3.0 x 2.6 cm in the right breast. This is the primary tumor size. Therefore, the patient does not meet the criteria for T1 (tumor size up to 2 cm) or T3 (tumor size more than 5 cm or direct extension to chest wall or skin)."",""The report also mentions two additional nodules in the lower outer quadrant of the right breast, measuring 0.7 x 0.6 x 0.5 cm and 0.5 x 0.4 x 0.4 cm. However, these are not the primary tumor and are not considered for T stage determination."",""The patient has no direct extension of the tumor to the chest wall or skin. This is confirmed by the report, which states that the tumor does not involve the nipple, overlying skin, or underlying chest wall."",""Based on the information provided, the patient's T stage is T2, as the primary tumor size is more than 2 cm but not more than 5 cm (5.2 cm).""]}",T2,True
TCGA-B6-A0I5.FA43414D-3757-43CC-8949-77F82DF4FA4D,1,T2,"According to the pathology report, the patient is a female (F) with a right breast mass. The tumor is multifocal, intraductal, and infiltrating ductal carcinoma with a grade of 2/3. The tumor extends to within 0.1mm of the surgical margin. There is no mention of the tumor size in the report. However, the AJCC guidelines state that 'in general, pathologic determination should take precedence over clinical determination of T size.' Since the report provides pathologic details but not the tumor size, we must classify it as Tis (carcinoma in situ) or T1 (tumor up to 20 mm in greatest dimension) but cannot determine which specifically."",""explanation"": ""Let's break down the information in the report and the AJCC guidelines to reach a decision:"",""points"":[{&quot;point&quot;: &quot;The report mentions that the patient is a female (F) with a right breast mass. This mass is described as multifocal, intraductal, and infiltrating ductal carcinoma with a grade of 2/3.&quot;}, {&quot;point&quot;: &quot;The tumor extends to within 0.1mm of the surgical margin, indicating that the tumor is close to the surgical margin but not beyond it.&quot;}, {&quot;point&quot;: &quot;The AJCC guidelines state that 'in general, pathologic determination should take precedence over clinical determination of T size.' However, in this case, the pathology report does not provide information on the tumor size.&quot;}, {&quot;point&quot;: &quot;Based on the information provided, we can classify the tumor as Tis (carcinoma in situ) or T1 (tumor up to 20 mm in greatest dimension), but we cannot determine the exact T stage without knowing the tumor size.&quot;}]}",T1 or Tis,True,1,T2,"Based on the pathology report, the patient is diagnosed with 'infiltrating ductal carcinoma, grade 2/3, nuclear grade moderately differentiated, the tumor extends to within 0.1mm of the surgical margin' in the right breast. The key information for T staging is the size of the tumor. However, the report does not provide a specific measurement of the tumor size in centimeters. Therefore, it is not possible to assign a definitive T stage based solely on this report.  \n\nHowever, the report does mention that the tumor extends to within 0.1mm of the surgical margin, which suggests that the tumor is very small, possibly less than 0.5 cm (T1a). But without a clear measurement, we cannot be certain. Therefore, the T stage for this patient should be determined by a healthcare professional using additional information from clinical examination, imaging studies, and other pathological findings.",Cannot determine based on the provided information.,True
TCGA-B6-A0I6.2D3D759B-D06A-4FC6-855A-5E9F83ADBED9,0,T1,"[The pathologic T stage is determined by the largest size of the primary tumor, as defined in the AJCC's TNM Staging System guidelines. In this report, the primary tumor is described as 'a large (5.0 x 5.0 x 4.0 cm.) infiltrating ductal carcinoma' (T2). This is consistent with the T2 category, which includes tumors larger than 20 mm but not larger than 50 mm in greatest dimension. Therefore, the pathologic T stage for this patient is T2.]",T2,True,0,T1,"[{""step"":1,""description"":""Reviewing the pathology report, the largest measured dimension of the tumor is 5.0 x 5.0 x 4.0 cm. This is greater than 2 cm, so the tumor does not meet the criteria for T1 (which includes tumors up to 2 cm in size).""},{""step"":2,""description"":""The tumor is also less than 5 cm in size, so it does not meet the criteria for T3 (which includes tumors greater than 5 cm in size).""},{""step"":3,""description"":""The report does not mention any direct extension to the chest wall or skin, so the tumor does not meet the criteria for T3 or T4.""},{""step"":4,""description"":""The report does mention that there are satellite nodules, but they are not separate from the main mass and are instead due to sclerosis and hemangioma. Therefore, these satellite nodules do not meet the criteria for T4c (which requires separate satellite nodules).""},{""step"":5,""description"":""Based on the information provided, the tumor meets the criteria for T2, which includes invasive breast carcinomas that are more than 2 cm but not more than 5 cm in size.""}]",T2,True
TCGA-B6-A0IB.CFC4801B-04BD-4FFC-911A-7B88E2FA4B49,2,T3,"According to the AJCC's TNM Staging System guidelines, the T stage for breast cancer is determined by the size of the primary tumor. In this pathology report, the 'GROSS EXAMINATION' section states that the 'main tumor mass' measures 6 x 3.5 x 3.0 cm. The 'DIAGNOSIS' section also mentions 'EXTENSIVE RESIDUAL INVASIVE CARCINOMA EXTENDING INTO THE DEEP DERMIS' in the right breast. Based on this information, the patient's pathologic T stage is T2, as it falls within the range of T2 (tumor >20 mm but ≤ 50 mm in greatest dimension).",T2,True,2,T3,"According to the pathology report, there are two tumor masses in the right breast. The first mass is a post-biopsy site with residual invasive ductal carcinoma that extends into the deep dermis (Block A8). The size of this mass is not explicitly stated in the report, but it is described as a 'biopsy cavity' and 'main tumor mass'. The second mass is located approximately 5 cm lateral to the first mass and measures approximately 3 cm in diameter. It is unclear whether this second mass is an isolated lesion or an extension of the first mass. \\nThe report does not provide enough information to determine the exact size of either tumor mass, making it difficult to assign a T stage based solely on this information. However, since the first mass has invaded the deep dermis and the size is not explicitly stated as being 2 cm or less, it is unlikely to be a T1 tumor. Additionally, there is no mention of direct extension to the chest wall or skin, which would be required for a T3 or T4 designation. Therefore, based on the information provided, it is most likely that the patient's T stage is T2, indicating a tumor size of more than 2 cm but not more than 5 cm. However, a definitive T stage assignment would require more precise measurements of the tumor masses.",T2,True
TCGA-B6-A0IE.DFCA9C6E-710E-4645-9CFC-A908AAD583F3,2,T3,"According to the AJCC's TNM Staging System guidelines, the T stage for breast cancer is defined as follows: \\nT1: Tumor ≤ 20 mm in greatest dimension \\nT2: Tumor >20 mm but ≤ 50 mm in greatest dimension \\nT3: Tumor >50 mm in greatest dimension \\nT4: Tumor of any size with direct extension to the chest wall and/or to the skin (ulceration or skin nodules). \\nThe report states that the largest dimension of the tumor is approximately 2.5 x 1.5 x 1 cm, which is equivalent to 3.5 cm in greatest dimension. This measurement puts the tumor in the T2 category, which is defined as a tumor >20 mm but ≤ 50 mm in greatest dimension. Therefore, the patient's pathologic T stage is T2.",T2,True,2,T3,"[{""step"":1,""description"":""Examining the gross examination section of the pathology report, we can see that the size of the specimen is 2.7 cm in thickness and 3.5 cm in greatest dimension. However, it is noted that this is a representative fragment of a larger lesion, so the true size of the tumor may be larger.""},{""step"":2,""description"":""The diagnosis section of the report indicates that this is a poorly differentiated carcinoma with extensive vascular invasion and features of lobular carcinoma, but no in situ component is present. The size of the tumor is not explicitly stated in the diagnosis.""},{""step"":3,""description"":""Since the size of the tumor is not explicitly stated in the diagnosis, we must rely on the measurements given in the gross examination section. However, we must keep in mind that these measurements may not represent the true size of the tumor.""},{""step"":4,""description"":""Based on the measurements given in the gross examination section, the size of the tumor appears to be larger than 2 cm but not more than 5 cm. Therefore, according to the rules provided, the T stage for this breast cancer would be T2. However, it is important to note that this is a preliminary determination based on the information provided in the pathology report and that the actual T stage should be determined by a healthcare professional based on a variety of factors, including clinical examination, imaging studies, and pathological findings.""}]",T2,True
TCGA-B6-A0IK.3A38A97C-2CBB-4802-9528-A4BBD62AEA4A,3,T4,"The report states that the 'BIOPSY OF LEFT BREAST' contains 'BREAST WITH INFILTRATING DUCTAL CARCINOMA (2.2 CM)' under gross examination. This indicates that the greatest dimension of the tumor is 2.2 cm. According to the AJCC TNM Staging System guidelines, T1 tumors have a greatest dimension of 2 cm or less, while T2 tumors are larger than 2 cm but not larger than 5 cm. Therefore, based on the information provided in the report and the AJCC guidelines, the patient's breast cancer has a pathologic T stage of T2.",T2,True,3,T4,"Based on the pathology report, the patient was diagnosed with 'BREAST WITH INFILTRATING DUCTAL CARCINOMA (2.2 CM), N.S.A.B.E NUCLEAR GRADE. MODERATELY-DIFFERENTIATED, HISTOLOGIC GRADE 3. COMEDO TYPE INTRADUCTAL CARCINOMA IS PRESENT REPRESENTING 5% OF THE TOTAL. TUMOR VOLUME. LYMPHATIC/VASCULAR INVASION IS PRESENT, BUT NO TUMOR IS SEEN IN DERMAL. LYMPHATICS. SURGICAL MARGINS ARE POSITIVE FOR CARCINOMA.' The size of the tumor is reported as 2.2 cm. According to the rules provided, T1 includes invasive breast carcinomas that are 2 cm or less in size, T2 includes invasive breast carcinomas that are more than 2 cm but not more than 5 cm in size, T3 includes invasive breast carcinomas that are more than 5 cm in size or tumors of any size with direct extension to the chest wall or skin, and T4 includes invasive breast carcinomas that have spread to the chest wall and/or the skin, resulting in ulceration or satellite nodules, or inflammatory carcinoma. Given that the tumor size is 2.2 cm, the patient's T stage is T2, as it is more than 2 cm but not more than 5 cm in size. It's important to note that this determination is based solely on the pathology report and that a healthcare professional should determine the T stage based on a variety of factors, including clinical examination, imaging studies, and pathological findings.",T2,True
TCGA-B6-A0IQ.0ED7357E-662C-4D65-82ED-29739919068F,2,T3,"According to the AJCC's TNM Staging System guidelines, the T stage for breast cancer is determined by the size of the primary tumor. In this pathology report, the tumor size is described as '5.5 x 4 x 3.5 cm' in the 'DIAGNOSIS' section. Therefore, we can use this information to determine the T stage.""T1"" refers to a tumor size of 20mm or less, ""T2"" refers to a tumor size of more than 20mm but not more than 50mm, ""T3"" refers to a tumor size of more than 50mm, and ""T4"" refers to a tumor of any size with direct extension to the chest wall and/or to the skin. Based on the size provided in the report, the tumor is larger than 20mm but not larger than 50mm, so the T stage is T2.",T2,True,2,T3,"[The following is a step-by-step explanation of how I arrived at the T stage based on the provided pathology report and rules.]:"","",""step 1"": ""From the report, we can see that the size of the tumor is 5.5 x 4 x 3.5 cm, which is larger than 2 cm but not more than 5 cm."","",""step 2"": ""Based on rule 2, this would classify the tumor as T2."","",""step 3"": ""However, it is important to note that the report also mentions that the tumor is within 1 mm of the deep margin. While this does not necessarily change the T stage, it is a significant finding that should be taken into account in the overall assessment and treatment of the patient.""",T2,True
TCGA-B6-A0RI.F2B21F52-74F4-44C5-9991-60EBCC4E43A6,3,T4,"To determine the pathologic T stage of the patient's breast cancer, we will follow the AJCC's TNM Staging System guidelines. The 'T' stage is based on the size of the tumor and its direct extension to the chest wall and/or skin. According to the pathology report, the following findings are relevant: \\n1. The largest dimension of the tumor is 1.5 x 2.8 x 1.0 cm. \\n2. The tumor comes within 0.2 cm of the deep surgical margin. \\n3. The tumor is located in the upper outer quadrant only. \\nBased on these findings, we can conclude that the tumor is greater than 1 mm but less than or equal to 20 mm in greatest dimension (T1). However, since the tumor comes within 0.2 cm of the deep surgical margin, it falls into the subcategory T1c, which indicates a tumor size of >10 mm but <= 20 mm in greatest dimension. Therefore, the pathologic T stage of the patient's breast cancer is T1c.",T1c,True,3,T4,"Based on the pathology report, the patient has a unilateral right breast cancer with a histologically confirmed infiltrating ductal carcinoma. The tumor measures 1.5 cm x 2.8 cm x 1.0 cm, which falls within the T1 category as it is less than or equal to 2 cm in size. However, since the exact measurement of the tumor size is not explicitly stated as being 0.1 cm or less, 0.1 cm but less than 0.5 cm, 0.5 cm but less than 1 cm, or 1 cm but less than 2 cm, we cannot further subclassify the T1 stage into T1mi, T1a, T1b, or T1c. Therefore, based on the given information, the T stage for this patient's breast cancer is T1.",T1,True
TCGA-B6-A0RO.EFA0354A-641D-4EC2-A1BE-4ACC7CE421DF,3,T4,"According to the AJCC's TNM Staging System guidelines, the T stage is based on the size of the primary tumor. In this report, the diagnosis states 'INFILTRATING DUCTAL CARCINOMA (2.5 CM)'. This indicates that the size of the tumor is 2.5 centimeters, which falls under T1. However, the 'T' category in the report also includes subcategories such as T1mi, T1a, T1b, and T1c, which further classify the tumor based on size. In this case, the tumor size is explicitly mentioned as 2.5 cm, which corresponds to T1c. Therefore, the pathologic T stage of the patient's breast cancer is T1c.",T1c,True,3,T4,"Based on the pathology report, the patient has invasive ductal carcinoma in the right breast, with the largest focus of the tumor measuring 2.5 cm. This is stated in the 'DIAGNOSIS' section of the report: 'INFILTRATING DUCTAL CARCINOMA (2.5 CM), NSABP HISTOLOGIC GRADE II/III'. \\n\\nThe rules provided for determining the T stage indicate that T2 includes invasive breast carcinomas that are more than 2 cm but not more than 5 cm in size. Therefore, based on the size of the tumor, the patient's T stage is T2.",T2,True
TCGA-B6-A0RT.64D53A4B-4735-4AD2-A413-520797F5F9CB,2,T3,"To determine the pathologic T stage of the patient's breast cancer, we will follow the AJCC's TNM Staging System guidelines. The T stage is based on the size of the tumor.""",T2,True,2,T3,"The report provides the gross tumor size in two different specimens, the incisional breast biopsy and the modified mastectomy. The incisional breast biopsy shows a gross tumor size of 3.5 x 1.7 x 2.1 cm, while the modified mastectomy shows a gross tumor size of at least 6.0 cm. In determining the T stage, we should consider the largest tumor size, which is found in the modified mastectomy specimen. Therefore, the patient's breast cancer is T2 or larger. However, the report does not indicate any direct extension to the chest wall or skin, or any spread to the chest wall and/or skin resulting in ulceration, satellite nodules, or inflammatory carcinoma. Therefore, we can exclude T3 and T4 stages. Based on the rules provided, the patient's breast cancer is classified as T2.",T2,True
TCGA-B6-A0WX.EE5BB205-D59B-4FEF-8D8F-D5720EDEB075,2,T3,"To determine the pathologic T stage of the patient's breast cancer, we will use the American Joint Committee on Cancer (AJCC) TNM Staging System guidelines. The pathologic T stage (pT) is based on the size of the primary tumor. According to the report, the size of the biopsy is 3.1 x 2.4 x 1.3 cm, and it is diffusely involved by invasive carcinoma. However, the actual size of the tumor itself is not explicitly stated in the report. Instead, it mentions that there is a 1.5 x 1.0 x 1.0 cm firm white-tan, ill-defined lesion, but it is unclear if this lesion represents the entire tumor or just a part of it. Thus, we cannot definitively assign a pT stage based solely on this information."",\",Unable to determine the T stage without further information,True,2,T3,"Based on the pathology report, the patient was diagnosed with 'INVASIVE PLEOMORPHIC LOBULAR CARCINOMA' in the left breast. The size of the biopsy specimen is 3.1 x 2.4 x 1.3 cm, and the tumor size is diffusely involved. However, the report does not provide a specific measurement of the tumor size. Therefore, we cannot categorically assign a T stage based solely on this report. \n\nHowever, we can make an educated guess based on the information provided. The tumor is described as a 'firm white-tan ill-defined lesion' that extends to the inked surgical margin within a 1.5 x 1.0 x 1.0 cm area. Although this does not necessarily mean that the tumor size is exactly 1.5 cm, it suggests that the tumor is relatively small, likely less than 2 cm. Therefore, based on the information provided, the most likely T stage is T1."",""conclusion"":""Based on the available information, the patient's T stage is likely T1. However, a definitive T stage assignment cannot be made without a more precise measurement of the tumor size.""}",T1,True
TCGA-B6-A0WY.C0E92852-4146-468C-9713-2DE9C3316B9F,2,T3,"The report states that 'GROSS TUMOR SIZE, 1.6 CM. SIZE OF INVASION COMPONENT, 1.5 CM.' This indicates that the largest dimension of the tumor is 1.6 cm and the size of the invasion component (which is what the T stage is based on for T1-T3) is 1.5 cm. According to the AJCC guidelines, T1 is defined as 'Tumor ≤ 20 mm in greatest dimension.' Since the size of the invasion component is 1.5 cm (or 15 mm), it falls within the T1 category. Therefore, the patient's pathologic T stage is T1.",T1,True,2,T3,"[{""step"":1,""description"":""Examining the report, the size of the invasive component of the tumor is stated as 1.5 cm."",""rule"":""T1: This stage includes invasive breast carcinomas that are 2 cm or less in size.""},{""step"":2,""description"":""The tumor size is within the T1 range, but further classification is needed."",""rule"":""T1 can be further divided into T1mi (microinvasion 0.1 cm or less), T1a (0.1 cm but less than 0.5 cm in size), T1b (0.5 cm but less than 1 cm in size), and T1c (1 cm but less than 2 cm in size).""},{""step"":3,""description"":""The size of the invasive component is 1.5 cm, which falls under the T1c category."",""rule"":""T1c (1 cm but less than 2 cm in size).""}]",T1c,True
TCGA-B6-A1KF.40EE8416-9DD8-457D-94AC-A871B5C62873,1,T2,"The report states that the 'GROSS TUMOR SIZE: 2.4 x 2.4 X 1.5 CM' and 'SIZE OF INVASIVE COMPONENT: 2. x 1.5 CM.' The largest dimension of the tumor is 2.4 cm. According to the AJCC guidelines, T1 includes T1mi and is defined as a tumor 2.0 cm or less in greatest dimension. Therefore, the patient's pathologic T stage is T1.",T1,True,1,T2,"The report states that the 'GROSS TUMOR SIZE: 2.4 x 2.4 x 1.5 cm' and the 'SIZE OF INVASIVE COMPONENT: 2.0 x 1.5 cm.' Since the size of the invasive component is less than 2 cm, the T stage is T1."",""details"":[{""step"":""1"",""info"":""Identify the size of the tumor from the pathology report.""},{""step"":""2"",""info"":""Compare the size to the T stage rules. In this case, the size of the invasive component is 2.0 x 1.5 cm, which falls under T1.""}]}",T1,True
TCGA-B6-A1KN.72996825-1FFA-4C51-8DB0-DA74BCB595EB,3,T4,"The report states that the 'SIZE OF INVASIVE COMPONENT: 6.4 x 5.2 x 2.5 CM.' This corresponds to the T category in the TNM staging system. According to the AJCC guidelines, T1 is defined as 'Tumor ≤ 20 mm in greatest dimension.' In this case, the greatest dimension of the tumor is 6.4 cm, which is larger than 20 mm. The next category, T2, is defined as 'Tumor >20 mm but ≤ 50 mm in greatest dimension.' The tumor size in this case is 6.4 cm, which is greater than 20 mm but less than or equal to 50 mm. Therefore, the pathologic T stage of the patient's breast cancer is T2.",T2,True,3,T4,"To determine the pathologic T stage of the patient's breast cancer, we will follow the rules provided and interpret the relevant information from the pathology report. The report includes a gross examination of the right breast, which was removed in a modified radical mastectomy. The mass in the breast measures 6.4 x 5.2 x 2.5 cm. According to rule 1, T1 includes invasive breast carcinomas that are 2 cm or less in size. However, the mass in this case is larger than 2 cm, so it does not meet the criteria for T1. Moving on to rule 2, T2 includes invasive breast carcinomas that are more than 2 cm but not more than 5 cm in size. The mass in this case falls within these measurements, so the T stage is T2. It is important to note that this is a general interpretation based on the provided information and the actual T stage should be determined by a healthcare professional based on a variety of factors.",T2,True
TCGA-B6-A3ZX.B3CFFF02-89AA-43AE-B19B-BEE6817AA997,2,T3,"The report states that there is 'INVASIVE ADENOCARCINOMA OF THE BREAST, HISTOLOGIC TYPE: DUCTAL, WITH LOBULAR FEATURES' in the left breast at the 11:00 site, and that the size of the aggregate of yellow-tan fibrofatty tissue containing the tumor is 1 x 0.6 x 0.2 cm. According to the AJCC TNM Staging System guidelines, T1 tumors are 20mm or less in greatest dimension. The largest dimension of the tumor in this report is 1 cm (10mm), which falls within the T1 category. Therefore, the pathologic T stage of the patient's breast cancer is T1.",T1,True,2,T3,"The pathology report provides information about the size of the tumor or the size of the sample taken from the tumor, which can be used to determine the T stage.  According to the rules, T1 includes invasive breast carcinomas that are 2 cm or less in size. However, the report does not provide a specific measurement of the tumor size in cm. Instead, it mentions that the sample from the breast (block A1) shows invasive adenocarcinoma of the breast, with a histologic type of ductal carcinoma with lobular features, and that the sample from the axillary node (block B1) shows metastatic ductal adenocarcinoma.  Therefore, based on the information provided in this report, it is not possible to determine the T stage of the breast cancer. Additional information about the size of the tumor is needed.",Unable to determine T stage with the provided information.,True
TCGA-B6-A409.CC77BA51-CE5A-4839-A27A-DD8F389A2733,0,T1,"The report states 'INVASIVE ADENOCARCINOMA OF THE BREAST. HISTOLOGIC TYPE: DUCTAL. NOTTINGHAM COMBINED HISTOLOGIC GRADE: 3 OF 3. TUBULE FORMATION SCORE: 3. NUCLEAR PLEOMORPHISM SCORE: 3. MITOTIC RATE SCORE: 3. LYMPHATIC/VASCULAR INVASION: NOT IDENTIFIED. IN-SITU CARCINOMA: PRESENT. TYPE OF IN-SITU CARCINOMA: COMEDO. NUCLEAR GRADE OF IN-SITU CARCINOMA: 3 OF 3. MICROCALCIFICATIONS ABSENT.' There is no information about the size of the tumor in the report, but the AJCC guidelines state that 'T1 includes T1mi' and 'T1 tumors are ≤ 20 mm in greatest dimension.' Since the report mentions invasive adenocarcinoma, it is clear that this is not Tis (carcinoma in situ). Therefore, we need to determine if the tumor is ≤ 20 mm or > 20 mm. The report does not provide enough information to make this determination, so it is not possible to assign a T stage based on the information provided.",Unknown,True,0,T1,"Based on the pathology report, the patient was diagnosed with 'INVASIVE ADENOCARCINOMA OF THE BREAST' with a size of 1.7 inches. To determine the T stage, we will compare this measurement with the size categories defined in the rules. 1.7 inches is approximately 4.32 cm (conversion from inches to cm: 1 inch = 2.54 cm, so 1.7 inches x 2.54 = 4.32 cm). According to the rules provided, T1 includes invasive breast carcinomas that are 2 cm or less in size. Since the tumor size is greater than 2 cm (4.32 cm > 2 cm), the patient's T stage is not T1. T2 includes invasive breast carcinomas that are more than 2 cm but not more than 5 cm in size. The patient's tumor size (4.32 cm) falls within this range. Therefore, the patient's T stage is T2.",T2,True
TCGA-BH-A0AZ.6721193F-FE9D-4573-BF2A-ABAECF57DFD9,2,T3,"The pathologic T stage (pT) is determined by the size of the primary tumor. In this report, the 'SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST' section indicates that the maximum dimension of the invasive component is 2.5 cm. According to the AJCC TNM staging system guidelines, this falls under T2 (Tumor >20 mm but <= 50 mm in greatest dimension). Therefore, the pathologic T stage for this patient is T2.",T2,True,2,T3,"The report provides the sizes of multiple invasive tumors in the right breast, with the maximum dimension of the largest invasive tumor being 2.5 cm. According to rule 1, T1 includes invasive breast carcinomas that are 2 cm or less in size. Therefore, we need to consider the largest tumor size to determine the T stage. The largest tumor size is 2.5 cm, which falls under T2 as per rule 2, which includes invasive breast carcinomas that are more than 2 cm but not more than 5 cm in size. Therefore, the pathologic T stage of the patient's breast cancer is T2.",T2,True
TCGA-BH-A0C1.1EC74EB3-9ECC-49B6-AE25-048A5F6A1D02,2,T3,"To determine the pathologic T stage of the patient's breast cancer, we will follow the AJCC's TNM Staging System guidelines. The T stage is based on the size of the primary tumor and its direct extension to the chest wall and/or skin. The report provides the gross measurement of the tumor as 7.0 cm. Now let's see the relevant T stage definitions from the guidelines:"",""T1"": ""Tumor ≤ 20 mm in greatest dimension"",""T2"": ""Tumor >20 mm but ≤ 50 mm in greatest dimension"",""T3"": ""Tumor >50 mm in greatest dimension"",""T4"": ""Tumor of any size with direct extension to the chest wall and/or to the skin (ulceration or skin nodules)."""",""notes"": ",T2,True,2,T3,"Based on the pathology report, the patient's breast cancer has a gross measurement of 7.0 cm, which exceeds the limit for T2 (5 cm or less) and falls within the limit for T3 (more than 5 cm). However, the report does not mention any direct extension to the chest wall or skin. Therefore, we cannot classify this as T3 based on the current information. Thus, we need to consider T2. The report also mentions that the tumor extends through the nipple into the upper papillary dermis of the skin but does not indicate ulceration or pagetoid extension. This information does not meet the criteria for T4. Based on these findings, the patient's breast cancer falls under T2, as the tumor measures more than 2 cm but not more than 5 cm in size, with no direct extension to the chest wall or skin. However, it is important to note that the actual T stage should be determined by a healthcare professional based on a variety of factors, including clinical examination, imaging studies, and pathological findings.",T2,True
TCGA-BH-A0DL.C96287D0-A60B-4BAA-ABA0-8AD4F48662DB,1,T2,"To determine the pathologic T stage of the patient's breast cancer, we will use the information from the pathology report and interpret it according to the AJCC's TNM Staging System guidelines. The maximum dimension of the invasive component is 2.5 cm (B. THE TUMOR SIZE IS 2.5 x 1.8 x 1.8 CM). According to the AJCC guidelines, T1 includes T1mi, and T1 tumors are ≤ 20 mm in greatest dimension. Since the tumor size is 2.5 cm, which is equal to 25 mm, it falls under T2. However, the report mentions that the tumor is 'T1 * N0 M0' in the 'T STAGE, PATHOLOGIC' section. This might be a typo or an error, as the tumor size is larger than 2 cm. Nonetheless, based on the given information, we will adhere to the report's T stage classification, and the final decision regarding the T stage is T1.",T1,True,1,T2,"To determine the pathologic T stage of the patient's breast cancer, we will use the information provided in the pathology report and the given rules. Here is the step-by-step interpretation: \\n1. According to the report, the maximum dimension of the invasive component of the tumor is 2.5 cm (part 1, B). \\n2. Based on rule 1, T1 includes invasive breast carcinomas that are 2 cm or less in size. \\n3. The report states that the tumor size is 2.5 x 1.8 x 1.8 cm, which is larger than 2 cm. However, the T stage is determined by the maximum dimension of the invasive component, not the overall size. \\n4. In this case, the maximum dimension of the invasive component is 2.5 cm. \\n5. Since the maximum dimension of the invasive component is 2.5 cm and is less than or equal to 2 cm, the tumor falls under T1. \\n6. To further classify the T1 stage, we need to consider the size of the microinvasion (T1mi), the size of the tumor between 0.1 cm and 0.5 cm (T1a), between 0.5 cm and 1 cm (T1b), and between 1 cm and 2 cm (T1c). \\n7. However, the report does not provide information about microinvasion or the size of the tumor in the specified ranges. \\n8. Therefore, based on the information provided, we can conclude that the pathologic T stage of the patient's breast cancer is T1, but we cannot further classify it into T1mi, T1a, T1b, or T1c.",T1,True
TCGA-BH-A18F.771497E1-473E-421A-A149-CFA58E95B728,1,T2,"The report states that 'THE INVASIVE TUMOR MEASURES 1.1 CM IN GREATEST DIMENSION (ON SLIDE IK)' and 'SIZE OF TUMOR: Maximum dimension invasive component: 11 mm.' The AJCC guidelines explain that the pathologic T classification should be determined by pathologic measurements, and in this case, the tumor is measured to be 1.1 cm (11 mm) in greatest dimension. According to the guidelines, T1 indicates a tumor up to 2 cm in size, and T2 indicates a tumor larger than 2 cm but not larger than 5 cm. Therefore, the patient's pathologic T stage is T1.",T1,True,1,T2,"The report states that the 'SIZE OF TUMOR: Maximum dimension invasive component: 11 mm.' This corresponds to T1c, which includes invasive breast carcinomas that are 1 cm but less than 2 cm in size. Therefore, the pathologic T stage of the patient's breast cancer is T1c.",T1c,True
TCGA-BH-A18G.7C92F144-4A84-4D9E-8A35-C059FD082150,0,T1,"To determine the pathologic T stage of the patient's breast cancer, we will follow the AJCC's TNM Staging System guidelines. The T stage is based on the size of the primary tumor. According to the report, the maximum dimension of the invasive component is 27 mm (2.7 cm). Now, let's see how the T stages are defined in the AJCC guidelines:"","" T1: Tumor ≤ 20 mm in greatest dimension"","" T2: Tumor >20 mm but ≤ 50 mm in greatest dimension"","" T3: Tumor >50 mm in greatest dimension"","" T4: Tumor of any size with direct extension to the chest wall and/or to the skin (ulceration or skin nodules)."" Since the tumor size in this case is greater than 20 mm but less than or equal to 50 mm, the pathologic T stage of the patient's breast cancer is T2.",T2,True,0,T1,"To determine the pathologic T stage of the patient's breast cancer, we will use the information provided in the pathology report and the given rules. Here is the step-by-step interpretation: \\n1. According to the report, the maximum dimension of the invasive component is 27 mm (2.7 cm). \\n2. Using rule 2, T2 stage includes invasive breast carcinomas that are more than 2 cm but not more than 5 cm in size. \\n3. The report states that the tumor measures 2.7 cm, which falls within the T2 range. \\n4. There is no mention of direct extension to the chest wall or skin, which would be required for a T3 stage. \\n5. The report also does not indicate any skin ulceration, satellite nodules, or inflammatory carcinoma, which would be required for a T4 stage. \\nTherefore, based on the given rules and the pathology report, the patient's breast cancer has a pathologic T stage of T2.",T2,True
TCGA-BH-A18J.589BC4DD-0079-4106-A2E6-9A48E9BD7DE2,3,T4,"The patient's pathology report includes the measurement of the largest focus of the tumor, which is 9.0 x 8.5 x 4.0 cm. According to the AJCC's TNM Staging System guidelines, T1 includes tumors up to 20 mm (2 cm) in greatest dimension. This patient's tumor is larger than 20 mm in greatest dimension, so it does not qualify as T1.  \\nT2 includes tumors larger than 20 mm but not larger than 50 mm in greatest dimension. This patient's tumor is larger than 20 mm but not larger than 50 mm in greatest dimension, so it meets the criteria for T2. Therefore, the pathologic T stage of the patient's breast cancer is T2.",T2,True,3,T4,"The report mentions that the size of the tumor is 9.0 by 8.5 by 4.0 cm. This exceeds the maximum size for T2 (5 cm) and falls within the size range for T3 (more than 5 cm). Additionally, the report states that the tumor extends to involve the nipple and epidermis of overlying ulcerated skin, indicating direct extension to the chest wall or skin. Therefore, the T stage for this patient's breast cancer is T3.",T3,True
TCGA-BH-A18M.4F67B7BE-68C1-40E1-8276-2D26B46C744D,2,T3,"The report states that the 'tumor mass: 2.5 by 2.0 by 3.5 cm.' This measurement refers to the size of the largest single focus of invasive tumor. According to the AJCC guidelines, the T category for patients treated with neoadjuvant therapy is determined by pathologic size and extension, with the ypT measured as the largest single focus of invasive tumor. Therefore, in this case, the tumor size is greater than 20 mm but less than or equal to 50 mm in greatest dimension, which corresponds to a T2 category. The report also mentions 'Tis (DCIS) Ductal carcinoma in situ' and 'Tis (Paget’s) Paget’s disease of the nipple NOT associated with invasive carcinoma and/or carcinoma in situ (DCIS and/or LCIS) in the underlying breast parenchyma.' However, these are Tis categories, which are not applicable in this case as the tumor size is greater than 20 mm. Additionally, the report states that 'Tumor in the lower inner quadrant is within 1.0 mm from the margin of resection.' This information is not relevant to determining the T category, as the T category is based on the size of the tumor and not its proximity to the margin of resection.",T2,True,2,T3,"To determine the pathologic T stage of the patient's breast cancer, we will follow the rules provided and interpret the relevant information from the pathology report. The report mentions the size of the tumor mass as 2.5 by 2.0 by 3.5 cm.  According to rule 1, T1 includes invasive breast carcinomas that are 2 cm or less in size. However, the tumor mass in this case is 2.5 cm (2.5 > 2), which means it does not fit into the T1 category.  Moving on to rule 2, T2 includes invasive breast carcinomas that are more than 2 cm but not more than 5 cm in size. The tumor mass in this case is 2.5 cm, which falls within the T2 category. Therefore, the pathologic T stage of the patient's breast cancer is T2.",T2,True
TCGA-BH-A18R.46DE21ED-1E08-4095-9B68-88D10AC74673,1,T2,"According to the AJCC's TNM Staging System guidelines, the T stage for breast cancer is determined by the size of the primary tumor. In this pathology report, it is stated that the patient had 'INFILTRATING DUCTAL CARCINOMA, 8.0 BY 3.0 BY 1.5 CM.' This indicates that the size of the primary tumor is 8.0 cm, which falls under T4 category: 'Tumor of any size with direct extension to the chest wall and/or to the skin (ulceration or skin nodules).' However, the report also mentions 'Invasion of the dermis alone does not qualify as T4.' Since there is no information about chest wall invasion or skin ulceration, we cannot classify it as T4. Therefore, we need to look at the maximum tumor size. The maximum tumor size mentioned is 8.0 cm, which falls under T3 category: 'Tumor >50 mm in greatest dimension.' So, the patient's pathologic T stage is T3.",T3,True,1,T2,"The report states that the size of the invasive ductal carcinoma is 8.0 by 3.0 by 1.5 cm. This is larger than 5 cm, which falls under T3 according to the rules provided."", ",T3,True
TCGA-BH-A1F2.FA781D93-C180-4453-BF95-B2D01B6CDB5C,3,T4,"[The pathologic T stage is determined by the size of the primary tumor in greatest dimension, according to the AJCC's TNM Staging System for breast cancer. The report states that the 'INFILTRATING, POORLY DIFFERENTIATED DUCT CARCINOMA' measures 4.7 by 2.5 by 2.0 cm. Therefore, the pathologic T stage is T2 (tumor >20 mm but <= 50 mm in greatest dimension).]",T2,True,3,T4,"Based on the pathology report, the patient's breast cancer is described as an 'infiltrating, poorly differentiated duct carcinoma, 4.7 by 2.5 by 2.0 cm, involving all four quadrants.' This information can be used to determine the T stage of the cancer according to the given rules. Here's a step-by-step breakdown of the process: \\n1. Identify the size of the tumor: The report states that the tumor is 4.7 cm by 2.5 cm by 2.0 cm. This means that the largest diameter of the tumor is 4.7 cm. \\n2. Compare the size to the T stage rules: According to rule 2, T2 tumors are defined as those that are 'more than 2 cm but not more than 5 cm in size.' Since the tumor in this case is larger than 2 cm (4.7 cm) and not more than 5 cm, it meets the criteria for a T2 tumor. \\n3. Confirm the absence of other T stage criteria: The report does not mention any direct extension to the chest wall or skin, which would be required for a T3 designation. Similarly, there is no mention of ulceration, satellite nodules, or inflammatory carcinoma, which would be required for a T4 designation. \\n4. Conclude the T stage: Based on the information provided in the report, the patient's breast cancer can be classified as a T2 tumor, as it is more than 2 cm but not more than 5 cm in size.",T2,True
TCGA-BH-A1F8.BAA6AA92-69C5-454B-A550-246E7DB1EBE3,3,T4,"According to the AJCC's TNM Staging System guidelines, the T stage for breast cancer is determined by the size of the primary tumor. The report states 'INFILTRATING DUCTAL CARCINOMA/ 4.0 BY 3.5 BY 3.0 CM.' This indicates that the greatest dimension of the tumor is 4.0 cm. Therefore, based on the guidelines, the patient's pathologic T stage is T2 (Tumor >20 mm but <= 50 mm in greatest dimension).",T2,True,3,T4,"To determine the pathologic T stage of the patient's breast cancer, we will follow the rules provided step-by-step. Here is the information from the report that is relevant to these rules: \""INFILTRATING DUCTAL CARCINOMA/ 4.0 BY 3.5 BY 3.0 CM\"" and \""tumor involving dermis and dermal lymphatics overlying tumor and extending into epidermis\"". \""TUMOR INVOLVING SUBAREOLAR AND NIPPLE LYMPHATICS\"" is not considered in the T staging. \""INTRADUCTAL COMPONENT, COMIDO VARIANT, COMPRISING 10% OF TUMOR\"" is also not considered in the T staging. \""TWELVE OF THIRTEEN (12/13) LYMPH NODES CONTAINING METASTATIC TUMOR WITH PROMIMENT PERINODAL EXTENSION IN 6. NODES. - TWO (2) ADDITIONAL TUMOR NODULES ARE SEEN AS PERIVASCULAR TUMOR NODULES WITHOUT RECOGNIZABLE NODAL FEATURES.\"" is not considered in the T staging. \""INFILTRATING DUCTAL CARCINOMA/ 4.0 BY 3.5 BY 3.0 CM\"" indicates that the tumor size is 4.0 cm, which is larger than 2 cm but not larger than 5 cm. Therefore, the T stage is T2 according to rule 2.\"", ",T2,True
TCGA-BH-A1FN.26F47A4F-B501-4C33-9D49-2039E98DBF26,1,T2,"The report states that 'Tumor greatest dimension 2.6 BY 1.6 BY 2.5 CM.' This corresponds to the T1c category in the AJCC guidelines, which is defined as 'Tumor >10 mm but <= 20 mm in greatest dimension.' Therefore, the pathologic T stage of the patient's breast cancer is T1.",T1,True,1,T2,"[The following is a step-by-step explanation of how I arrived at the T stage for this patient's breast cancer.]\n\n1. I began by reviewing the pathology report to locate the size of the tumor. The report states that the tumor is '2.6 by 2.6 by 2.5 cm.' This measurement is consistent with the T1 category, which includes invasive breast carcinomas that are 2 cm or less in size.\n\n2. Since the tumor size falls within the T1 category, I then looked at the subcategories T1mi, T1a, T1b, and T1c. These subcategories are based on the size of the tumor: T1mi (microinvasion 0.1 cm or less), T1a (0.1 cm but less than 0.5 cm in size), T1b (0.5 cm but less than 1 cm in size), and T1c (1 cm but less than 2 cm in size).\n\n3. The report states that the tumor is '2.6 by 2.6 by 2.5 cm.' This size is greater than 1 cm but less than 2 cm, which falls within the T1c subcategory.\n\nTherefore, based on the information provided in the pathology report and the rules for determining the T stage, the patient's breast cancer has a pathologic T stage of T1c.",T1c,True
TCGA-BH-A1FR.B6E6765F-14BC-4D3D-9266-EF8065354070,3,T4,"The report mentions the size of the tumor as 'a tumor mass, 2.2 by 1.7 by 3.0 cm'. According to the AJCC's TNM Staging System guidelines, T1 includes T1mi and T1 is divided into T1a (>1 mm but ≤ 5 mm), T1b (>5 mm but ≤ 10 mm), and T1c (>10 mm but ≤ 20 mm). The tumor size in this report is 3.0 cm (the greatest dimension), which falls under T1c (>10 mm but ≤ 20 mm). Therefore, the pathologic T stage of the patient's breast cancer is T1c.",T1c,True,3,T4,"Based on the pathology report, the patient's breast cancer can be classified according to the rules provided as follows:\nThe report states that the tumor mass measures 3.0 by 2.2 by 1.7 cm. This is greater than 2 cm (T2 threshold), but no further information is provided about direct extension to the chest wall or skin. Therefore, we cannot classify this as T3 or T4.\nThe report does not mention any clinical examination or imaging studies, so we cannot consider those factors.\nBased on the pathological findings alone, the T stage for this patient's breast cancer would be T2.",T2,True
TCGA-BH-A208.4F943D12-E769-45F3-86BE-75193786DD4E,1,T2,"To determine the pathologic T stage of the patient's breast cancer, we will follow the AJCC's TNM Staging System guidelines. The T stage is based on the size of the primary tumor. According to the report, the patient had a 'nearly full thickness Duke's type B carcinoma, 6.0 cm in greatest dimension, with extensive vascular permeation including nipple.' This indicates that the tumor is larger than 50 mm in greatest dimension. In the AJCC guidelines, this is classified as T3: 'Tumor >50 mm in greatest dimension.' Therefore, the patient's pathologic T stage is T3.",T3,True,1,T2,"Based on the pathology report, the patient was diagnosed with a left mastectomy specimen with a diagnosis of neutrophilic ductal carcinoma, not otherwise specified, with a size of 6.0 cm (RY 2.0 by 270 cm). The tumor is poorly differentiated, with intermediate nuclear grade, extending to within 1 mm of the line of resection, and massive vascular permeation, including nipple. Additionally, three out of fifteen (3/15) axillary lymph nodes were positive for metastatic tumor with capsular and extracapsular extension. \\nThe T stage is determined by the size of the tumor and its extension to the chest wall or skin. In this case, the tumor is 6.0 cm, which exceeds the maximum size for T2 (5 cm). Furthermore, the report mentions direct extension to the chest wall, which is consistent with T3. Therefore, the patient's T stage is T3.",T3,True
TCGA-D8-A1JC.B4DB830F-BFA4-47F5-94C7-D95984315866,1,T2,"According to the AJCC's TNM Staging System guidelines, the T stage is based on the size of the primary tumor. In this report, the tumor size is described as '11 x 7 x 3 cm'. To determine the T stage, we compare this measurement to the definitions provided in the guidelines. The T stage definitions are as follows: T1 is ≤ 20 mm, T2 is > 20 mm but ≤ 50 mm, T3 is > 50 mm. The given tumor size of '11 x 7 x 3 cm' is equivalent to a maximum dimension of approximately 11 cm. This exceeds the 50 mm limit for T2, and thus the tumor is classified as T3. The final decision is T3.",T3,True,1,T2,"The report mentions the size of the tumor as 11 x 7 x 3 cm. According to rule 1, T1 includes invasive breast carcinomas that are 2 cm or less in size. In this case, the greatest tumor dimension is 11 cm, which is more than 2 cm and exceeds the limit for T1. According to rule 2, T2 includes invasive breast carcinomas that are more than 2 cm but not more than 5 cm in size. The greatest tumor dimension in this case is 11 cm, which is more than 5 cm and exceeds the limit for T2. According to rule 3, T3 includes invasive breast carcinomas that are more than 5 cm in size or tumors of any size with direct extension to the chest wall or skin. The report does not mention any direct extension to the chest wall or skin, but the tumor size is 11 cm, which is more than 5 cm and falls under T3. However, the final decision regarding the T stage should be made by a healthcare professional based on a variety of factors, including clinical examination, imaging studies, and pathological findings.",T3,True
TCGA-E2-A14R.0B6DCA80-3108-4D25-B095-3EC704598B23,1,T2,"The report states that the 'gross assessment 2.0 cm mass >0.5 cm all margins and 1.0 cm satellite nodule at inferior margin' in specimen D. The AJCC guidelines define T1 as a tumor 20mm or less in greatest dimension, and T2 as a tumor greater than 20mm but not greater than 50mm in greatest dimension. Given that the primary tumor in this report measures 4.0 x 3.0 x 0.9 cm, which is equivalent to 108mm in greatest dimension (4cm), the patient's pathologic T stage is T3.",T3,True,1,T2,"The report states that the 'gross assessment 2.0 cm mass >0.5 cm all margins and 1.0 cm satellite nodule at inferior margin' in specimen D. This indicates that the size of the tumor is 2.0 cm, which falls under T1 stage according to the rules provided. However, since the tumor has a satellite nodule at the inferior margin, it is more specifically classified as T1c, which includes invasive breast carcinomas that are 1 cm but less than 2 cm in size with satellite nodules."",""determination"":""T1c""}",T1c,True
TCGA-E2-A15D.1FE4EB4C-FEF8-486A-B39D-6F9F023FDAC4,1,T2,"According to the AJCC's TNM Staging System guidelines, the T stage is based on the size of the primary tumor.""T1"" tumors are 20mm or less in greatest dimension. The report states that the size of the invasive ductal carcinoma is 2.2 cm, which is within the T1 category. However, there are no further subcategories provided in the report to determine if it's T1a, T1b, or T1c. Therefore, the most appropriate T stage based on the information provided would be T1.",T1,True,1,T2,"The report states that the 'Invasive ductal carcinoma, SBR Grade 1, measuring 2.2-cm' and 'Tumor size: 2.2cm' in the Synoptic Report. According to rule 1, T1 includes invasive breast carcinomas that are 2 cm or less in size. Therefore, the patient's breast cancer falls under the T1 category. However, the report does not provide information about the subcategories of T1 (T1mi, T1a, T1b, or T1c). As a result, the T stage for this patient is T1, but the subcategory cannot be determined based on the information provided.",T1,True
TCGA-E2-A1LK.6CC4E6EF-6664-448E-933E-FFA9117C7ABF,3,T4,"According to the AJCC's TNM Staging System guidelines, the T stage is based on the size of the primary tumor in the breast. In this pathology report, the largest focus of the invasive ductal carcinoma measures 6.8 cm. According to the AJCC guidelines, a T stage of T3 is assigned when the tumor is greater than 50 mm in greatest dimension. Therefore, the patient's pathologic T stage is T3.",T3,True,3,T4,"The report states that the 'Tumor size: 6.8cm.' This information can be found in the 'SYNOPTIC REPORT - BREAST' section. According to the rules provided, T1 includes invasive breast carcinomas that are 2 cm or less in size, T2 includes invasive breast carcinomas that are more than 2 cm but not more than 5 cm in size, and T3 includes invasive breast carcinomas that are more than 5 cm in size. Since the tumor size in this report is 6.8 cm, it falls under T3. However, it is important to note that the actual T stage should be determined by a healthcare professional based on a variety of factors, including clinical examination, imaging studies, and pathological findings.",T3,True
TCGA-EW-A423.0BB6CAC8-CE26-461F-A9FE-46E28E96A368,1,T2,"The patient's pathology report indicates an invasive lobular carcinoma with a greatest dimension of 2 cm (T1c). The report also mentions pleomorphic lobular carcinoma in situ; however, this does not affect the T stage as it only applies to ductal carcinoma in situ (DCIS). The TNM staging system guidelines state that T1 includes T1mi, and T0 and T1 tumors with nodal micrometastases only are excluded from Stage IIA and are classified as Stage IB. Therefore, the patient's pathologic T stage is T1.",T1,True,1,T2,"The report states that the 'Size of Largest Invasive Carcinoma: Greatest dimension of largest focus of invasion: 2 cm.' This is the key piece of information we need to determine the T stage. According to the rules provided, a tumor that is 2 cm or less in size falls under the T1 category. Therefore, the patient's pathologic T stage is T1.",T1,True
TCGA-GI-A2C8.4AABCBD1-DF12-45E1-9307-21D6CB0894A9,3,T4,"The patient's pathology report includes the following relevant information: \n1. The tumor size is 2.4 cm, which falls under T2 in the TNM staging system: T2 - Tumor >20 mm but <= 50 mm in greatest dimension.\n2. There is no information provided about the tumor extending to the chest wall or skin, and the report specifically states that the tumor does not invade the muscle or bone. Therefore, it does not meet the criteria for T3 or T4.\n3. The tumor is described as being present in the dermis of the skin and nipple, but this does not necessarily mean it ulcerates or forms satellite nodules or edema in the skin, which are required for T4b.\n4. The report also states that the tumor is more than 1 cm from all margins.\nGiven this information, the patient's pathologic T stage is T2.",T2,True,3,T4,"The report states 'Final size of invasive tumor: 2.4 cm.' According to rule 1, T1 includes invasive breast carcinomas that are 2 cm or less in size. However, the report specifies that the tumor is 2.4 cm, which is larger than 2 cm. Therefore, we cannot classify this tumor as T1.  \\nRule 2 states that T2 includes invasive breast carcinomas that are more than 2 cm but not more than 5 cm in size. The report states that the tumor is 2.4 cm, which falls within this range. Therefore, the tumor is classified as T2.",T2,True
TCGA-JL-A3YW.476488A9-3708-4B11-854A-C91B583C7804,1,T2,"The report mentions 'Infiltrating Lobular Carcinoma grade II' and 'Tumour nuclei constitute approximately 70% of the total nuclei.' This indicates that the tumor is invasive, which means we can exclude Tis (carcinoma in situ) and T1mi (tumor ≤ 1 mm in greatest dimension).""Moderate nuclear pleomorphism"" suggests a higher grade, but the exact measurement of the tumor size is not provided. However, the report mentions 'Tumour >10 mm but ≤ 20 mm in greatest dimension' in relation to the Modified Bloom and Richardson's grading system. Therefore, based on the AJCC guidelines, this patient's pathologic T stage is T1c (Tumor >10 mm but ≤ 20 mm in greatest dimension).",T1c,True,1,T2,"Based on the pathology report, the patient has been diagnosed with Infiltrating Lobular Carcinoma grade II, which is a type of invasive breast carcinoma. The report mentions that the tumor size is not explicitly stated in centimeters. However, it does mention that the tumor nuclei constitute approximately 70% of the total nuclei. This suggests that the tumor is likely to be larger than 1 cm but less than 2 cm in size. Therefore, based on the rules provided, the patient's pathologic T stage would be T1c, which includes invasive breast carcinomas that are 1 cm but less than 2 cm in size.",T1c,True
TCGA-JL-A3YX.25782EF0-8786-446E-ADBA-21F489844237,1,T2,"To determine the pathologic T stage of the patient's breast cancer, we will follow the AJCC's TNM Staging System guidelines. The T stage is based on the size of the tumor in greatest dimension.""Tis"" represents carcinoma in situ, while stages T1, T2, T3, and T4 are divided into subcategories based on tumor size."",T1"" tumors are 20mm or less in greatest dimension, with further subdivisions based on specific size ranges. T2 tumors are larger than 20mm but not larger than 50mm, T3 tumors are larger than 50mm, and T4 tumors involve direct extension to the chest wall and/or skin."",T1"" is further divided into T1mi (tumor measuring 1mm or less in greatest dimension), T1a (tumor more than 1mm but not more than 5mm), T1b (tumor more than 5mm but not more than 10mm), and T1c (tumor more than 10mm but not more than 20mm)."",T1mi NEC (not elsewhere classiﬁed)"" is not mentioned in the report."",T1a"", T1b"", and T1c"" tumors can be ruled out based on the report mentioning the tumor size being larger than 20mm."",T2"" tumors are larger than 20mm but not larger than 50mm, which can also be ruled out since the report mentions the tumor size being larger than 50mm."",T3"" tumors are larger than 50mm, which is in line with the report mentioning the tumor size being larger than 50mm."",T4"" tumors involve direct extension to the chest wall and/or skin, which is not mentioned in the report."",The report mentions that the tumor is 100% viable with no areas of necrosis and measures larger than 50mm in greatest dimension. This corresponds to a T3 tumor according to the AJCC's TNM Staging System.",T3,True,1,T2,"Based on the pathology report, the patient was diagnosed with Infiltrating Lobular Carcinoma of the left breast, grade II. The report mentions that 'Section examined reveal breast tissue an infiltrative neoplastic lesion composed of cells. showing moderate pleomorphism with nuclear hyperchromasia and eosinophilic cytoplasm. Few mitotic figures are seen. Almost 100% of the tumor is viable. No areas of necrosis are seen.' The key information for T staging here is the size of the tumor, which is not explicitly mentioned in the report. However, since the report mentions that the tumor is invasive, it can be assumed that the tumor is T1 or larger. The absence of skin or chest wall involvement and the lack of ulceration or satellite nodules suggest that the tumor is not T4. Without further information on the size of the tumor, it cannot be definitively classified as T1, T2, or T3. Therefore, additional information is needed to accurately determine the T stage of this patient's breast cancer.",Unknown,True
TCGA-PL-A8LV.D35DBECD-5241-4562-85CC-2822BB338279,3,T4,"The pathologic report states that the gross assessment of the tumor size is 5x3x2 cm, which translates to a greatest dimension of 5 cm. According to the AJCC TNM staging system for breast cancer, a T stage is determined by the greatest dimension of the tumor. In this case, a tumor size of 5 cm falls under the T2 category, which includes tumors >20 mm but ≤ 50 mm in greatest dimension. The pathologist has assigned a pT2 stage, which supports our interpretation. Therefore, the patient's pathologic T stage is T2.",T2,True,3,T4,"The report provides the size of the tumor as 5x3x2 cm. According to the rules for determining the T stage, T2 includes invasive breast carcinomas that are more than 2 cm but not more than 5 cm in size. The tumor size in this report falls within this range (5 cm in the largest dimension), so the pathologic T stage of the patient's breast cancer is T2.",T2,True
TCGA-PL-A8LX.E6DD0840-4D71-4EEC-B559-F6BFC9E7E68B,3,T4,"To determine the pathologic T stage of the patient's breast cancer, we will follow the AJCC's TNM Staging System guidelines. The T stage is based on the size of the tumor. According to the pathology report, the tumor is an invasive ductal carcinoma located in the left breast with the closest margin being 5mm deep. There is no information about the tumor size in millimeters in the gross or microscopic assessment sections. However, the report mentions focal areas of necrosis, which suggests a larger tumor size. But without specific measurements, we cannot rely on this observation alone. Thus, we cannot definitively assign a T stage based solely on the provided information.",Unable to determine T stage,True,3,T4,"The pathology report provides information about the size of the tumor, which is necessary to determine the T stage. The report mentions that the tumor is an invasive ductal carcinoma in the left breast, and that it is 5mm away from the deep resection margin. However, the report does not provide a specific measurement of the tumor size in terms of the T stage categories (T1, T2, T3, T4).""\n""Therefore, we need to rely on the information that the tumor is 5mm away from the deep resection margin. Since the T stage categories are based on the maximum size of the tumor, and since the tumor is only 5mm away from the margin, it is unlikely that the tumor is larger than 2 cm (T1) or 5 cm (T2). Furthermore, there is no mention of direct extension to the chest wall or skin, which would be required for a T3 or T4 classification.""\n""Based on this information, we can infer that the tumor is likely to be a T1 or T2 stage breast cancer. However, without a specific measurement of the tumor size, we cannot determine the exact T stage. Therefore, additional information is needed to make a definitive determination of the T stage.",T1 or T2,True
TCGA-PL-A8LY.8C97B391-96B4-468D-AAA3-24E196DE03CA,2,T3,"To determine the pathologic T stage of the patient's breast cancer, we will follow the AJCC's TNM Staging System guidelines. According to the report, the patient is a female with a malignant tumor in the right breast. The gross assessment shows a tumor measuring 3.4x2.5x1.5 cm. The histological diagnosis confirms Invasive Ductal Carcinoma."",""steps"":[""Step 1: Identify the primary tumor. Based on the report, the primary tumor is in the right breast."",""Step 2: Measure the size of the tumor. The gross assessment shows the tumor measures 3.4x2.5x1.5 cm, which is approximately 4.9 cm in greatest dimension (since √(3.4*3.4 + 2.5*2.5) = 4.89 cm, rounded up to 4.9 cm)."",""Step 3: Compare the tumor size with the AJCC's TNM Staging System categories. A T1 tumor measures 2.0 cm or less in greatest dimension, a T2 tumor measures more than 2.0 cm but not more than 5.0 cm, a T3 tumor measures more than 5.0 cm, and a T4 tumor involves the chest wall or the skin."",""Step 4: Since the tumor measures approximately 4.9 cm in greatest dimension, it falls under the T2 category, which applies to tumors measuring more than 2.0 cm but not more than 5.0 cm.""],",T2,True,2,T3,"Based on the information provided in the pathology report and the rules for determining the T stage, the patient's breast cancer can be classified as follows:""\n1. The tumor size is reported as 3.4x2.5x1.5 cm in the gross assessment section. This exceeds the 2 cm limit for T1 stage tumors, and falls within the 2-5 cm range for T2 stage tumors. Therefore, we can conclude that the tumor is at least a T2."""",""steps"":[""\n1. Review the gross assessment of the tumor size: 3.4x2.5x1.5 cm.\n2. Compare the tumor size to the T stage size limits.\n3. Determine that the tumor size falls within the T2 range (>2 cm but ≤ 5 cm).\n4. Confirm that there is no direct extension to the chest wall or skin, or any signs of ulceration, satellite nodules, or inflammatory carcinoma.\n5. Conclude that the tumor is a T2 based on the provided information.""],""conclusion"":""T2""}The patient's breast cancer is classified as T2 stage, as the tumor size (3.4x2.5x1.5 cm) falls within the 2-5 cm range for T2 stage tumors. There is no mention of direct extension to the chest wall or skin, or any signs of ulceration, satellite nodules, or inflammatory carcinoma in the report, which would have indicated a higher T stage. Therefore, based on the information provided, the patient's breast cancer is classified as T2 stage. However, it is important to note that the actual T stage should be determined by a healthcare professional based on a variety of factors, including clinical examination, imaging studies, and pathological findings. The information provided in the pathology report alone may not be sufficient to accurately determine the T stage. Additionally, the report does not provide information on any substaging within the T1 or T2 categories, so no further subclassification can be made based on the information provided. Therefore, the final decision regarding the T stage is T2. Confidence: 90%.",T2,True
TCGA-PL-A8LZ.436F3280-98C7-4FA9-BD6F-1B02CAF1D262,3,T4,"To determine the pathologic T stage of the patient's breast cancer, we will follow the AJCC's TNM Staging System guidelines. The T stage is based on the size of the tumor. According to the pathology report, the gross assessment of the tumor size is 4x3x2 cm. This means the tumor is more than 20 mm in greatest dimension but not more than 50 mm, which corresponds to T2 based on the AJCC guidelines.",T2,True,3,T4,"Based on the information provided in the pathology report and the rules for determining the T stage, we can determine the size of the tumor and whether it has extended to the chest wall or skin. The report states that the tumor is 4x3x2 cm in size. This is larger than 2 cm, but there is no mention of direct extension to the chest wall or skin. Therefore, we can rule out T3 and T4 stages.""""""T1: This stage includes invasive breast carcinomas that are 2 cm or less in size. However, the report states that the tumor is 4x3x2 cm in size, which is larger than 2 cm. Therefore, the T1 stage is not applicable.""""""T2: This stage includes invasive breast carcinomas that are more than 2 cm but not more than 5 cm in size. The report states that the tumor is 4x3x2 cm in size, which falls within this range. Therefore, the T2 stage is applicable.""""""T3: This stage includes invasive breast carcinomas that are more than 5 cm in size or tumors of any size with direct extension to the chest wall or skin. The report does not mention direct extension to the chest wall or skin, and the tumor size is less than 5 cm. Therefore, the T3 stage is not applicable.""""""T4: This stage includes invasive breast carcinomas that have spread to the chest wall and/or the skin, resulting in ulceration or satellite nodules, or inflammatory carcinoma. The report does not mention any spread to the chest wall or skin, ulceration, satellite nodules, or inflammatory carcinoma. Therefore, the T4 stage is not applicable.""""""Based on this analysis, the pathologic T stage of the patient's breast cancer is T2.""} | {",T2,True
TCGA-S3-AA15.DD2B9E47-8C67-4599-B0B6-0D30DE727B55,1,T2,"The patient's pathology report mentions that the 'Greatest dimension of largest focus of invasion over 0.1 cm: 1.1 cm.' This measurement refers to the size of the largest invasive carcinoma in the breast. According to the AJCC TNM Staging System guidelines, a T1 tumor is defined as a tumor that measures 20 mm or less in greatest dimension. Since the largest invasive carcinoma in this patient's breast measures 1.1 cm (or 11 mm), it falls within the T1 category. However, the AJCC guidelines further divide T1 tumors into three subcategories: T1mi (tumor microinvasion), T1a (tumor >1 mm but ≤ 5 mm), T1b (tumor >5 mm but ≤ 10 mm), and T1c (tumor >10 mm but ≤ 20 mm). Given the measurement of 1.1 cm (11 mm) for the largest invasive carcinoma in this patient's breast, the tumor is classified as T1c.",T1c,True,1,T2,"The report states that the 'Greatest dimension of largest focus of invasion over 0.1 cm: 1.1 cm.' This information refers to the size of the largest invasive carcinoma, which is used to determine the T stage. According to the rules provided, a tumor between 1 cm and 2 cm in size falls under the T1c category. Therefore, the pathologic T stage of the patient's breast cancer is T1c.",T1c,True
